neurology

FDA greenlights Bayer’s first-in-class drug and non-hormonal option in the vasomotor-symptom space.

Mini “miBrains” replicate key brain cell types, enabling personalized disease research and drug testing.

New software and hardware tools that collect data while a person types can detect fine motor impairment — a possible sign of neurodegeneration.

COPD breakthroughs, billion-dollar biotech bets, brain-computer trials, and a historic push for women’s health led the news this week.

Discover causes, treatments, and patient-driven solutions for chronic hiccups, a rare and mysterious condition.

LIVE May 25th, 2021 at 10:30 AM ET
This webinar will discuss new drug delivery approaches to overcoming the blood-brain barrier.

Researchers have established a new sensory neuron model that could replace animal models